Jayne David R.W. — SEC Form 4 filings
SEC reporting owner CIK 1838242. 2 Form 4 filings on record with FilingPulse; latest filed 2024-11-25.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2024-05-22 to 2024-11-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 4,946 shares, $28,390 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 4,946 shares @ $5.74 ($28,390) in Aurinia Pharmaceuticals Inc., filed 2024-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | Director | 2 | — | 1 leg · 4,946 sh · $28,390 | 2 |
Form 4 filings — Jayne David R.W.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-11-25 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 12,135 @ $0 · Grant/award (A): 18,641 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 4,946 @ $5.74 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1838242 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →